Silk Road Medical (NASDAQ:SILK – Get Rating) had its target price decreased by Argus from $70.00 to $55.00 in a research report issued on Monday, The Fly reports. Argus’ price target points to a potential upside of 74.49% from the stock’s current price. SILK has been the topic of several other reports. Piper Sandler decreased […]
TimesSquare Capital Management LLC lowered its position in shares of Silk Road Medical, Inc (NASDAQ:SILK – Get Rating) by 4.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 957,770 shares of the company’s stock after selling 49,670 shares during the […]
Arcadia Investment Management Corp MI acquired a new position in shares of Silk Road Medical, Inc (NASDAQ:SILK – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 3,751 shares of the company’s stock, valued at approximately $198,000. A number of other hedge funds […]
B. Riley started coverage on shares of Silk Road Medical (NASDAQ:SILK – Get Rating) in a research report sent to investors on Friday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $58.00 price objective on the stock. Other equities analysts have also recently issued reports about the company. Citigroup upgraded Silk Road […]